Drug Enforcement D-0051-2025

Lack of Sterility Assurance

Status

Terminated

Classification

Class II

Report Date

November 27, 2024

Termination Date

March 28, 2025

Product Information

Product description
BEVACIZUMAB (AVASTIN)1.25mg/0.05mL, Sterile Injection, 0.5 mL Single-Dose Syringe, Rx Only, Repackaged by: Medivant Healthcare: 24416 N 19th Ave, Phoenix, AZ, NDC 81483-0041-1
Product quantity
27,560 Syringes
Reason for recall
Lack of Sterility Assurance
Recall initiation reason
—
Initial firm notification
Letter
Distribution pattern
Nationwide Within U.S.

Location & Firm

Recalling firm
Tailstorm Health INC
Address
24416 N 19th Ave Ste 200, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-0051-2025
Event ID
95718
Recall initiation date
November 6, 2024
Center classification date
November 18, 2024
Code info
Lot #: D24005, Exp. Date 20 February 2025; D24006, Exp. Date 21 February 2025; D24007, Exp. Date 22 February 2025; D24008, Exp. Date 19 March 2025; D24009, Exp. Date 20 March 2025; D24012, Exp. Date 25 April 2025.
More code info
—